Greenspring Advisors LLC Buys New Shares in UnitedHealth Group Incorporated $UNH

Key Points

• Greenspring Advisors initiated a UnitedHealth Group position of 3,329 shares valued at approximately $1.38 million. Institutional investors and hedge funds collectively own 87.86% of UNH.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $455.92; several firms recently raised their targets to as high as $478.
• UnitedHealth exceeded quarterly earnings expectations, reporting $6.38 in EPS and $112.03 billion in revenue, and declared a quarterly dividend of $2.32 per share, representing a 2.4% annualized yield.

Greenspring Advisors LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 3,329 shares of the healthcare conglomerate's stock, valued at approximately $1,384,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. Anfield Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Joseph Group Capital Management purchased a new position in shares of UnitedHealth Group during the fourth quarter worth $27,000. Nalls Sherbakoff Group LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at $27,000. Finally, Lifetime Wealth Management P.C. purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $29,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total value of $205,000.00. Following the completion of the sale, the chief executive officer owned 16,497 shares in the company, valued at approximately $6,763,770. This represents a 2.94% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.19% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on UNH. KeyCorp raised their target price on UnitedHealth Group from $400.00 to $475.00 and gave the stock an "overweight" rating in a report on Tuesday, July 14th. Leerink Partners raised their price objective on shares of UnitedHealth Group from $400.00 to $462.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 17th. Sanford C. Bernstein reiterated an "outperform" rating on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a research report on Friday, July 17th. Finally, Bank of America reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Monday, July 20th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $455.92.

UnitedHealth Group Trading Up 0.2%

UNH stock opened at $390.94 on Monday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The stock has a market cap of $350.90 billion, a price-to-earnings ratio of 25.16, a PEG ratio of 1.35 and a beta of 0.62. The business's 50-day moving average is $413.99 and its 200 day moving average is $356.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the prior year, the company earned $4.08 EPS. The firm's revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 19.81 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's payout ratio is presently 59.72%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is reportedly prioritizing Medicare Advantage profitability over rapid membership growth by tightening benefits, improving pricing and controlling costs. The strategy could support stronger margins and more sustainable earnings, even if enrollment growth moderates. Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?
• Positive Sentiment: Zacks Research added UNH to its Rank #1, or “Strong Buy,” lists for overall stocks, value stocks and income stocks. The repeated favorable rankings may reinforce investor confidence in the shares. New Strong Buy Stocks for August 21st
• Positive Sentiment: Analysts raised several forward EPS estimates, including Q1 2028 to $7.36 from $6.78 and Q2 2028 to $7.19 from $5.84. A separate report also noted an increase in the Q1 EPS estimate, while Zacks maintained a Strong Buy rating. Q1 EPS Estimate for UnitedHealth Group Increased by Analyst
• Neutral Sentiment: Forecast revisions were mixed: Q3 2027 EPS was reduced to $4.74 from $4.81 and Q4 2027 to $4.07 from $4.12, partially offsetting the increases for 2028.
• Negative Sentiment: Aon expects U.S. employer health-care costs to rise 9.5% in 2027. Persistent medical-cost inflation could pressure insurers’ margins and increase pricing, benefit and utilization-management challenges for UnitedHealth. AON Sees No Relief From Health-Cost Inflation

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source